Adma Biologics, Inc. (ADMA) — 10-Q Filings

10-Q Filings (6)

• ADMA Biologics' Revenue Jumps 20% on Strong Product Sales — Nov 5, 2025 Risk: medium
  ADMA Biologics, Inc. reported robust financial performance for the nine months ended September 30, 2025, with total revenues increasing to $371.01 million from
• ADMA Biologics Confirms Large Accelerated Filer Status in Q2 2025 10-Q — Aug 6, 2025 Risk: low
  ADMA Biologics, Inc. filed its 10-Q for the quarter ended June 30, 2025, indicating it is a large accelerated filer and has met all SEC filing requirements. The
• ADMA Biologics Files Q1 2025 10-Q Report — May 7, 2025 Risk: low
  ADMA Biologics, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The company, incorporated in Delaware, is involved in the bio
• ADMA Biologics Files Q3 2024 10-Q Report — Nov 7, 2024 Risk: medium
  ADMA Biologics, Inc. filed its Q3 2024 10-Q report on November 7, 2024, detailing its financial performance for the period ending September 30, 2024. The compan
• ADMA Biologics Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
  ADMA Biologics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results for the second quarter and the first six months
• ADMA Biologics Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk:
  ADMA BIOLOGICS, INC. (ADMA) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. ADMA Biologics, Inc. filed a 10-Q report for the quarter ended March 31

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX